Ketamine for Teens with Suicidal Thoughts in the ER
Treatments studied
Part of Mental health clinical trials.
This study tests whether a single dose of ketamine, given through an IV, can quickly reduce suicidal thoughts in teenagers who come to the emergency department. It aims to find a faster way to help teens in crisis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old.
- You are having thoughts of killing yourself right now.
- Your suicidal thoughts are moderate to severe (you feel a strong urge to act on them).
- You are medically stable and cleared by the ER doctor.
- You have not taken any opioids in the last 2 hours.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.
This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.
This trial tests if a ketamine injection under the skin (subcutaneous) can safely help teenagers with severe depression and suicidal thoughts or actions. It is for teens who are already receiving standard depression treatment but still have high symptom scores.
This study tests whether ketamine (a medication) combined with a specific type of therapy called DBT can help people with treatment-resistant depression and borderline personality disorder who are having thoughts of suicide. You would receive ketamine infusions alongside structured therapy sessions over 6 months.
This study tests whether ketamine plus a structured crisis-response plan can help reduce suicidal thoughts for adults admitted from the ER. It also aims to make care in the emergency setting more consistent and effective.
This Phase 3 study tests ketamine to reduce ongoing suicidal thoughts and help prevent another suicide attempt in youth after a recent attempt. It will compare ketamine treatment against standard care to see if it helps improve safety and reduce suicide risk.
Hear when a new Suicidal Ideation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.